Choosing the right CRO-partner for your preclinical programs is more than a procurement decision. Preclinical data guide major investments, define development paths, and shape clinical strategy. The CRO you choose should excel beyond the study execution — they must understand the biology, the question, and the decision behind the data. At Redoxis AB, we are a specialized preclinical CRO focused on inflammation and autoimmune diseases.
Our approach is built on:
- Deep disease-area expertise
- Selected and well-characterized in vivo, ex vivo, and in vitro models
- Mechanistic insight and translational relevance
- Close scientific collaboration throughout the project Every study is project-tailored — designed around the therapeutic modality, development stage, and the specific questions that need to be answered
The goal is always the same: robust, relevant data that support confident decision-making and reduce downstream risk. We’re now in the last stages preparing the launch our new website, where we’ll share a clearer and more structured view of our models, capabilities, and scientific way of working.